Year |
Citation |
Score |
2006 |
Hambleton M, Hahn H, Pleger ST, Kuhn MC, Klevitsky R, Carr AN, Kimball TF, Hewett TE, Dorn GW, Koch WJ, Molkentin JD. Pharmacological- and gene therapy-based inhibition of protein kinase Cα/β enhances cardiac contractility and attenuates heart failure Circulation. 114: 574-582. PMID 16880328 DOI: 10.1161/Circulationaha.105.592550 |
0.534 |
|
2005 |
Pathak A, del Monte F, Zhao W, Schultz JE, Lorenz JN, Bodi I, Weiser D, Hahn H, Carr AN, Syed F, Mavila N, Jha L, Qian J, Marreez Y, Chen G, et al. Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circulation Research. 96: 756-66. PMID 15746443 DOI: 10.1161/01.Res.0000161256.85833.Fa |
0.658 |
|
2003 |
Song Q, Schmidt AG, Hahn HS, Carr AN, Frank B, Pater L, Gerst M, Young K, Hoit BD, McConnell BK, Haghighi K, Seidman CE, Seidman JG, Dorn GW, Kranias EG. Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy. The Journal of Clinical Investigation. 111: 859-67. PMID 12639992 DOI: 10.1172/Jci16738 |
0.74 |
|
2002 |
Schmidt AG, Zhai J, Carr AN, Gerst MJ, Lorenz JN, Pollesello P, Annila A, Hoit BD, Kranias EG. Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure. Cardiovascular Research. 56: 248-59. PMID 12393095 DOI: 10.1016/S0008-6363(02)00541-2 |
0.651 |
|
2002 |
Schmidt AG, Gerst M, Zhai J, Carr AN, Pater L, Kranias EG, Hoit BD. Evaluation of left ventricular diastolic function from spectral and color M-mode Doppler in genetically altered mice. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 15: 1065-73. PMID 12373248 DOI: 10.1067/Mje.2002.121863 |
0.55 |
|
2002 |
Carr AN, Kranias EG. Thyroid hormone regulation of calcium cycling proteins. Thyroid : Official Journal of the American Thyroid Association. 12: 453-7. PMID 12165106 DOI: 10.1089/105072502760143818 |
0.622 |
|
2002 |
Chu G, Carr AN, Young KB, Lester JW, Yatani A, Sanbe A, Colbert MC, Schwartz SM, Frank KF, Lampe PD, Robbins J, Molkentin JD, Kranias EG. Enhanced myocyte contractility and Ca2+ handling in a calcineurin transgenic model of heart failure. Cardiovascular Research. 54: 105-16. PMID 12062367 DOI: 10.1016/S0008-6363(02)00230-4 |
0.717 |
|
2002 |
Carr AN, Schmidt AG, Suzuki Y, del Monte F, Sato Y, Lanner C, Breeden K, Jing SL, Allen PB, Greengard P, Yatani A, Hoit BD, Grupp IL, Hajjar RJ, DePaoli-Roach AA, et al. Type 1 phosphatase, a negative regulator of cardiac function. Molecular and Cellular Biology. 22: 4124-35. PMID 12024026 DOI: 10.1128/Mcb.22.12.4124-4135.2002 |
0.647 |
|
2001 |
Carr AN, Sutliff RL, Weber CS, Allen PB, Greengard P, de Lanerolle P, Kranias EG, Paul RJ. Is myosin phosphatase regulated in vivo by inhibitor-1? Evidence from inhibitor-1 knockout mice. The Journal of Physiology. 534: 357-66. PMID 11454956 DOI: 10.1111/J.1469-7793.2001.00357.X |
0.566 |
|
2001 |
Dash R, Frank KF, Carr AN, Moravec CS, Kranias EG. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium. Journal of Molecular and Cellular Cardiology. 33: 1345-53. PMID 11437540 DOI: 10.1006/Jmcc.2001.1394 |
0.729 |
|
2000 |
Brittsan AG, Carr AN, Schmidt AG, Kranias EG. Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. The Journal of Biological Chemistry. 275: 12129-35. PMID 10766848 DOI: 10.1074/Jbc.275.16.12129 |
0.66 |
|
1999 |
Carr AN, Sato Y, Neirouz Y, Schmidt A, Hoit BD, Grupp IL, Allen PB, Greengard P, Kranias EG. Protein phosphatase inhibitor-1 ablation results in depressed cardiac contractility in response to β-adrenergic stimulation and decreased phosphorylation of phospholamban Journal of Cardiac Failure. 5: 7. DOI: 10.1016/S1071-9164(99)91369-6 |
0.54 |
|
1999 |
Carr AN, Suzuki Y, Sato Y, Schmidt A, Kadambi VJ, Hoit BD, Grupp IL, Jing S, Field LJ, DePaoli-Roach A, Kranias EG. Cardiac-specific overexpression of the sarcoplasmic reticulum and glycogen targeting subunit of the type I phosphatase does not result in altered cardiac contractility Journal of Cardiac Failure. 5: 7. DOI: 10.1016/S1071-9164(99)91368-4 |
0.595 |
|
Show low-probability matches. |